EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy

Nicht supprimierte Virämie und niedrigere CD4-Zahl mit schnellerem Telomerabbau bei afrikanischen Kindern mit perinataler HIV-Infektion unter langfristiger antiretroviraler Therapie assoziiert

Julian P G Shellard, Emily Carr iD, Gianni Tam-McMillan iD, Emma W Mao iD, Hilda Mujuru iD, Hildah Banda Mabuda, Molly Chisenga iD, Tsitsi Bandason iD, Nyasha V Dzavakwa iD, Lackson Kasonka iD, Victoria Simms iD, Celia L Gregson iD und 3 weitere

The Journal of Infectious Diseases · 16.06.2026 · 233 (6) · e1407-e1417

DOI: 10.1093/infdis/jiag060 ↗

Auf einen Blick

Bei 842 Kindern mit perinataler HIV-Infektion in Sambia und Simbabwe war eine HIV-VL >1000 Kopien/ml mit kürzerer Telomerlänge verbunden. Niedrigere CD4-Zahlen waren ebenfalls mit kürzerer Telomerlänge und schnellerem Telomerabbau assoziiert.

Fragestellung

Wie hängen HIV-Viruslast und CD4-Zahl mit Telomerlänge und Telomerabbau bei Kindern mit HIV unter cART zusammen?

Methode

Analyse von Kindern 11–19 Jahre mit perinatal erworbenem HIV aus der VITALITY-Studie; Telomerlänge an Baseline und nach 48 Wochen per qPCR. Querschnittlich und longitudinal mit multivariabler linearer Regression analysiert.

Ergebnisse

Baseline: N = 842; 80,5 % mit VL <60 Kopien/ml, 7,8 % mit 60–1000 Kopien/ml, 11,6 % mit >1000 Kopien/ml. VL >1000 Kopien/ml: kürzere TL (β = −0,239; 95 %-KI −0,451 bis −0,026; P = .028). Niedrigere CD4-Zahl: kürzere TL (β = −0,038; 95 %-KI −0,009 bis −0,066; P = .009).

Schlussfolgerung der Autor:innen

Eine HIV-VL >1000 Kopien/ml unter cART war bei Kindern in Afrika innerhalb eines Jahres mit einer Verschlechterung des immunologischen Alters verbunden und könnte das spätere Komorbiditätsrisiko erhöhen.

Kernaussagen

  • VL >1000 Kopien/ml war mit kürzerer Telomerlänge assoziiert.
  • Niedrigere CD4-Zahl war mit kürzerer Telomerlänge verbunden.
  • Hohe VL war auch mit schnellerem Telomerabbau assoziiert.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 07.02.2026. Verfasst von Julian P G Shellard und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, HIV Infections, Telomere, Viremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, CIHR, Chinese Academy of Medical Sciences.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human immunodeficiency virus (HIV-1) infection leads to reduced telomere length (TL), a biomarker of immune aging. We investigated relationships between HIV viral load (VL) and CD4 count with TL and its rate of attrition in children with HIV from Zambia and Zimbabwe.

Methods

Buffy coat was obtained at baseline and 48 weeks from children aged 11–19 years with perinatally acquired HIV taking combination antiretroviral therapy (cART) for >6 months recruited into the VITALITY trial. Relative TL was measured using monochrome multiplex quantitative polymerase chain reaction, standardizing units for analysis. Cross-sectional analyses used multivariable linear regression adjusting for age, sex, and study site; longitudinal analysis additionally adjusted for baseline TL.

Results

Among participants at baseline (N = 842; mean ± SD age, 15.5 ± 2.6 years; 53.2% female), 678 (80.5%) had HIV VL <60 copies/mL, 66 (7.8%) had 60–1000 copies/mL, and 98 (11.6%) had >1000 copies/mL. The mean CD4 count was 584 ± 243 cells/μL. Compared to participants with VL <60 copies/mL, those with VL >1000 copies/mL had shorter TL (β = −.239 [95% confidence interval {CI}, −.451 to −.026]; P = .028), whereas those with 60–1000 copies/mL did not (P = .836). Lower CD4 cell count was associated with shorter TL (β = −.038 [95% CI, −.009 to −.066] per 100 CD4 cells/μL; P = .009). In longitudinal analysis (n = 783) after mean 336 ± 6 days, those with HIV VL >1000 copies/mL at both timepoints had an accelerated telomere attrition rate (β = −.276 [95% CI, −.546 to −.005]; P = .046) compared with participants with VL <1000 copies/mL. Lower baseline CD4 count was associated with faster telomere attrition rate (β = −.033 [95% CI, −.008 to −.057]; P = .009).

Conclusions

HIV VL >1000 copies/mL among children with HIV on cART in Africa is associated with a degradation of immune age within 1 year, which may increase risk of comorbidities later in life. Clinical Trials Registration PACTR202009897660297.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Retroviral AgentsHIV InfectionsTelomereViremiaAdolescentChildFemaleHumansMaleYoung AdultAnti-HIV AgentsCD4 Lymphocyte CountCross-Sectional StudiesHIV-1Infectious Disease Transmission, VerticalLongitudinal StudiesViral LoadZambiaZimbabwe

Stichwörter der Autor:innen

HIV/AIDSagingpediatricstelomere

Substanzen

Anti-HIV AgentsAnti-Retroviral Agents

Autor:innen und Institutionen

  • Centre for Immuno-Oncology, Nuffield Department of Medicine, ⁠University of Oxford, Oxford, United Kingdom.
  • Institute for Infection and Immunity, City St George's, University of London, London, United Kingdom.
  • Department of Paediatrics, University of Zimbabwe, Harare, Zimbabwe.
  • University Teaching Hospital, Women and Newborn Hospital, University of Zambia, Lusaka, Zambia.
  • Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.
  • International Statistics and Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

ORCID-Profile: Emily Carr, Gianni Tam-McMillan, Emma W Mao, Hilda Mujuru, Molly Chisenga, Tsitsi Bandason, Nyasha V Dzavakwa, Lackson Kasonka, Victoria Simms, Celia L Gregson, Sarah L Rowland-Jones

Förderung

  • European Union
  • CIHR
  • Chinese Academy of Medical Sciences
  • Canadian Institutes of Health Research

Zitieren

APA

Shellard, J. P. G., Carr, E., Tam-McMillan, G., Mao, E. W., Mujuru, H., Banda Mabuda, H., Chisenga, M., Bandason, T., Dzavakwa, N. V., Kasonka, L., Simms, V., Gregson, C. L., Ferrand, R. A., Rowland-Jones, S. L., & Hsieh, A. Y. Y. (2026). Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy. The Journal of Infectious Diseases, 233(6), e1407-e1417. https://doi.org/10.1093/infdis/jiag060

Vancouver

Shellard JPG, Carr E, Tam-McMillan G, Mao EW, Mujuru H, Banda Mabuda H, et al. Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy. The Journal of Infectious Diseases. 2026;233(6):e1407-e1417. doi:10.1093/infdis/jiag060

BibTeX
@article{Shellard2026,
  author = {Shellard, Julian P G and Carr, Emily and Tam-McMillan, Gianni and Mao, Emma W and Mujuru, Hilda and Banda Mabuda, Hildah and Chisenga, Molly and Bandason, Tsitsi and Dzavakwa, Nyasha V and Kasonka, Lackson and Simms, Victoria and Gregson, Celia L and Ferrand, Rashida A and Rowland-Jones, Sarah L and Hsieh, Anthony Y Y},
  title = {Unsuppressed Viremia and Lower CD4 Count Associated With Faster Telomere Attrition in African Children With Perinatal Human Immunodeficiency Virus on Long-term Antiretroviral Therapy},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {233},
  number = {6},
  pages = {e1407--e1417},
  doi = {10.1093/infdis/jiag060}
}
Kostenlos starten →